Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quidel files for flu test clearance in the US:

This article was originally published in Clinica

Executive Summary

Quidel, of San Diego, California, has filed for FDA 510(k) clearance of its rapid, point-of-care test for influenza A and B. The test was developed with UK pharmaceutical company Glaxo Wellcome, which has a treatment for the virus (called Relenza) under review by the agency. Early diagnosis could help prevent the spread of the virus, which results in 300,000 admissions to US hospitals every year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel